Gryphon Financial Partners LLC Gsk PLC Transaction History

Gryphon Financial Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$38.57 - $42.69 $235,007 - $260,110	-6,093 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $230,315 - $260,110	6,093 New	6,093 $244,000
Q3 2018 Nov 06, 2018	SELL	$39.75 - $42.69 $8,148 - $8,751	-205 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $1,980 - $2,138	50 Added 32.26%	205 $8,000
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $2,243 - $2,489	-62 Reduced 28.57%	155 $6,000
Q4 2017 Feb 09, 2018	BUY	$35.34 - $41.9 $7,668 - $9,092	217	217 $8,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gryphon Financial Partners LLC with notifications on news.